You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
| Title |
Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma
|
|---|---|
| Published in |
Frontiers in oncology, June 2023
|
| DOI | 10.3389/fonc.2023.1192472 |
| Pubmed ID | |
| Authors |
Jiuhui Xu, Chenglong Chen, Kunkun Sun, Qianyu Shi, Boyang Wang, Yi Huang, Tingting Ren, Xiaodong Tang |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 July 2023.
All research outputs
#17,945,056
of 26,262,977 outputs
Outputs from Frontiers in oncology
#8,313
of 22,956 outputs
Outputs of similar age
#225,259
of 389,075 outputs
Outputs of similar age from Frontiers in oncology
#290
of 1,080 outputs
Altmetric has tracked 26,262,977 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,956 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 389,075 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,080 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.